TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.810
-0.100 (-5.24%)
Nov 18, 2026, 4:00 PM EST - Market closed
TherapeuticsMD Revenue
TherapeuticsMD had revenue of $1.26M in the quarter ending September 30, 2026, with 60.59% growth. This brings the company's total for the last twelve months to $3.75M, up 33.94% year-over-year. In the year 2025, TherapeuticsMD had annual revenue of $3.02M with 71.61% growth. That makes TherapeuticsMD the 40,879th largest company in the world by revenue and 5,476th in the United States.
Revenue (ttm)
$3.75M
Revenue Growth
+33.94%
P/S Ratio
5.59
Revenue / Employee
$3,745,000
Employees
1
Market Cap
20.95M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.02M | 1.26M | 71.61% |
| Dec 31, 2024 | 1.76M | 459.00K | 35.25% |
| Dec 31, 2023 | 1.30M | -68.66M | -98.14% |
| Dec 31, 2022 | 69.96M | -16.99M | -19.54% |
| Dec 31, 2021 | 86.95M | 22.08M | 34.03% |
| Dec 31, 2020 | 64.87M | 15.23M | 30.67% |
| Dec 31, 2019 | 49.65M | 33.55M | 208.38% |
| Dec 31, 2018 | 16.10M | -678.25K | -4.04% |
| Dec 31, 2017 | 16.78M | -2.58M | -13.32% |
| Dec 31, 2016 | 19.36M | -786.45K | -3.90% |
| Dec 31, 2015 | 20.14M | 5.12M | 34.05% |
| Dec 31, 2014 | 15.03M | 6.25M | 71.23% |
| Dec 31, 2013 | 8.78M | 4.96M | 129.85% |
| Dec 31, 2012 | 3.82M | 1.73M | 82.84% |
| Dec 31, 2011 | 2.09M | 846.26K | 68.14% |
| Dec 31, 2010 | 1.24M | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | 941.86K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| InterCure | 84.76M |
| Rockwell Medical | 72.58M |
| Aytu BioPharma | 57.57M |
| Biofrontera | 48.26M |
| SCYNEXIS | 18.88M |
| China Pharma Holdings | 3.91M |
| Optimi Health | 123.70K |
| Incannex Healthcare | 12.00K |
TXMD News
- 5 days ago - TherapeuticsMD Announces Third Quarter 2026 Financial Results - Business Wire
- 5 days ago - TherapeuticsMD Quarterly report: Q3 2026 - Filings
- 5 days ago - TherapeuticsMD Earnings release: Q3 2026 - Filings
- 3 months ago - TherapeuticsMD Announces Second Quarter 2026 Financial Results - Business Wire
- 3 months ago - TherapeuticsMD Earnings release: Q2 2026 - Filings
- 3 months ago - TherapeuticsMD Quarterly report: Q2 2026 - Filings
- 6 months ago - TherapeuticsMD reports Q1 EPS 1c vs. (6c) last year - TheFly
- 6 months ago - TherapeuticsMD Announces First Quarter 2026 Financial Results - Business Wire